Quality assurance of internal mammary node irradiation in the DBCG IMN2 study
For IMN_ESTRO_IC1-3, we found a significantly higher IMN dose coverage in right-sided than in left-sided patients supporting treatment according to study guidelines in the DBCG IMN2 study.
Authors
- Mette S. Thomsen (ORCID: https://orcid.org/0000-0002-6675-7781)
- Stine Korreman (ORCID: https://orcid.org/0000-0002-3523-382X)
- Birgitte Vrou Offersen (ORCID: https://orcid.org/0000-0001-7356-2096)
- Anders W. Mølby Nielsen (ORCID: https://orcid.org/0000-0003-2843-2879)
- Jens Overgaard (ORCID: https://orcid.org/0000-0002-0814-8179)
- Ebbe Laugaard Lorenzen (ORCID: https://orcid.org/0000-0003-1895-733X)
- Lasse Refsgaard (ORCID: https://orcid.org/0000-0001-7329-8416)
- Lise Bech Jellesmark Thorsen (ORCID: https://orcid.org/0000-0002-4533-1642)
- Karen Andersen
- Ingelise Jensen
- Martin Berg
- Emma Skarsø Buhl
Institutions
- University of Southern Denmark (DK)
- Aalborg University Hospital (DK)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
- Gentofte Hospital (DK)
- Vejle Sygehus (DK)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1016/j.radonc.2024.110600
- Citations
- 12
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.42
Funders
- Aarhus Universitet
- Kræftens Bekæmpelse
- Institut for Klinisk Medicin, Aarhus Universitet